| NCT ID | NCT06875414 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Regina Elena Cancer Institute |
| Condition | Breast Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-11-14 |
| Primary Completion | 2024-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2022-11-14 with a primary completion date of 2024-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective pilot study examining the couple's dyadic attitudes from diagnosis to 24 months later when one member is affected by illness and the adaptive strategies the couple employs when stressful events occur.
Eligibility Criteria
INCLUSION CRITERIA: * Woman diagnosed with stage 1, 2 or 3 breast cancer * age\> 18 years (patient and partner) * The partner must have lived with the woman for at least 6 months at diagnosis and treatment * Patients under treatment at the radiotherapy clinic * Subjects available and able to answer questionnaires, interviews, and / or participate in focus groups * Informed consent EXCLUSION CRITERIA: Cognitive deficits and / or inability to comply with the provisions of the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06875414 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06875414 currently recruiting?
Yes, NCT06875414 is actively recruiting participants. Contact the research team at ilaria.farina@ifo.it for enrollment information.
Where is the NCT06875414 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT06875414 clinical trial?
NCT06875414 is sponsored by Regina Elena Cancer Institute. The trial plans to enroll 40 participants.